Research Funding

April 28, 2022

Submit research grants for the next issue of Med News


March

  • Caryl E. Sortwell, PhD, and co-investigators Joe Patterson, PhD, Kathy Steece-Collier, PhD, and Matthew Benskey, PhD, Department of Translational Neuroscience, were awarded $419,527 by Takeda for “Synucleinopathy Triggered NLRP3 Inflammasome” (March 2022 - March 2023).
  • Anna Moore, PhD, Precision Health Program, was awarded $420,000 by the National Cancer Institute for “Novel Prostate cancer therapy based on m-aconitase inhibition” (March 2022 -February 2024).

February

  • Morteza Mahmoudi, PhD, Department of Radiology, was awarded $2,767,629 by the NIH for "A Nanostructured Skin Patch to Heal Chronic Wounds" (February 2022 - January 2027).
  • Jae Wook Jeong, PhD, Department of Obstetrics, Gynecology and Reproductive Biology, was awarded $2,867,991 by the NIH to study the role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer (February 2022 - January 2027).
  • Rodlescia Sneed, PhD, MPH, Division of Public Health, was awarded $50,000 by the Blue Cross Blue Shield of Michigan Foundation for "HEALTH (Harnessing Education and Lifestyle Change for Health) for Returning Citizens: A Feasibility Study."

January

  • Cara Poland, MD, Department of Obstetrics, Gynecology and Reproductive Biology, was awarded $189,035 by the University of Michigan for the Michigan Opioid Collaborative (January 2022 - December 2022)
  • Genna Moldovan, graduate student in the Department of Obstetrics, Gynecology and Reproductive Biology, was awarded $38,023 by the NIH for “Cytoskeletal regulation of the Hippo and Notch1 signaling pathways in endometrial stromal cell decidualization and endometriosis” (January 2022 - December 2023).
  • Yong Song, PhD, Department of Obstetrics, Gynecology and Reproductive Biology, was awarded $23,528 by the Society of Endometriosis and Uterine Disorders for “Regulation of Endometriotic Lesion Development by E-proteins” (January 2022 - December 2024).

2021

  • Lorenzo F. Sempere, PhD, Department of Radiology, was awarded $2.8M by the National Cancer Institute for “Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer” (December 2021 - November 2026).
  • Andre Bachmann, PhD, Department of Pediatrics and Human Development, was awarded $27,720 by the MSU-Molecular Discovery Group to study ODC inhibitors for the treatment of MYC- and MYCN-driven cancers (November 2021 - October 2022).
  • Andre Bachmann, PhD, Department of Pediatrics and Human Development, was awarded $50,000 by the MSU Discretionary Funding Initiative to study the targeting eIF5A hypusination for the treatment of endometrial cancer (November 2021 - May 2023).
  • Cara Poland, MD, Department of Obstetrics, Gynecology and Reproductive Biology, was awarded $114,165 by the Michigan Department of Health and Human Services for “Substance Use Disorder Demonstration” (October 2021 - September 2022).
  • Anna Moore, PhD, Precision Health Program, was awarded $7,966,972 by the NIH for the Large Animal Facility for Imaging and Image-guided Therapies at MSU (September 2021 - May 2026).
  • Michael Roland Williams, PhD, Department of Pediatrics & Human Development, was awarded $2.3M from NIH Mental Health to study the development of a small tag for the anterograde delivery of cargos (September 2021 - September 2024).
  • Xiaopeng Li, PhD, Department of Pediatrics and Human Development, was awarded $553,359 per year for four years by the NIH to study how loss of CFTR leads to host defense defects in CF small airway epithelia, and whether viral vector-mediated delivery of CFTR cDNA to CF smal (August 2021 - July 2025).
  • Jeffrey P. MacKeigan, PhD, Department of Pediatrics and Human Development, was awarded $402,400 by the National Cancer Institute for “Therapeutic Potential of Targeting DNA Repair Deficiency in TSC- investigate the therapeutic potential of drugs targeting both germline DNA damage repair mutations and somatic mutations” (July 2021 - June 2023).
  • Anna Moore, PhD, Precision Health Program, was awarded $3,515,167 by the NIH for “anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals” (July 2021 - June 2026)
  • Ryan Thomas, MD, Department of Pediatrics and Human Development, was awarded the Cystic Fibrosis Foundation Care Center Grant of $79,150 (July 2021 - June 2022).

Grants submitted before our previous issue of Med News can be found at the Office of Research website.